Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11

Trial Status

Completed1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT01159028Phase 1Completed
Clinical Trial of BP1001 (L-Grb-2 Antisense Oligonucleotide) in CML, AML, ALL & MDS
Acute Lymphoblastic LeukemiaMyelodysplastic SyndromePh1 Positive CML+1 more
Principalinvestigator

Research Network

Collaboration Network

12 collaborators·11 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Jorge Cortes, MD

M.D. Anderson Cancer Center

Moderately Similar
24 trials

Shared therapeutic areas:

Myelodysplastic SyndromesPrecursor Cell Lymphoblastic Leukemia-LymphomaPh1 Positive CML+1 more

Worked with same sponsors:

Bio-Path Holdings, Inc.
Collaborated on 1 trial
Similarity Score44%

Beata Holkova, MD

Massey Cancer Center

Related
3 trials

Shared therapeutic areas:

Precursor Cell Lymphoblastic Leukemia-LymphomaMyelodysplastic Syndromes
Similarity Score15%

Qifa Liu

Nanfang Hospital, Southern Medical University

Related
33 trials

Shared therapeutic areas:

Myelodysplastic SyndromesPrecursor Cell Lymphoblastic Leukemia-Lymphoma
Similarity Score15%

Mitchell S Cairo, MD

New York Medical College

Related
13 trials

Shared therapeutic areas:

Myelodysplastic SyndromesPrecursor Cell Lymphoblastic Leukemia-Lymphoma
Similarity Score15%

Farhad Ravandi-Kashani, MD

M.D. Anderson Cancer Center

Related
14 trials

Shared therapeutic areas:

Myelodysplastic SyndromesPrecursor Cell Lymphoblastic Leukemia-Lymphoma
Similarity Score15%

Mary Horowitz, MD

Center for International Blood and Marrow Transplant Research

Related
24 trials

Shared therapeutic areas:

Precursor Cell Lymphoblastic Leukemia-LymphomaMyelodysplastic Syndromes
Similarity Score15%

Richard W Childs, M.D.

National Heart, Lung, and Blood Institute (NHLBI)

Related
15 trials

Shared therapeutic areas:

Precursor Cell Lymphoblastic Leukemia-LymphomaMyelodysplastic Syndromes
Similarity Score15%

Yves Beguin, MD, PhD

CHU-ULg

Related
7 trials

Shared therapeutic areas:

Precursor Cell Lymphoblastic Leukemia-LymphomaMyelodysplastic Syndromes
Similarity Score15%

David Avigan, MD

Beth Israel Deaconess Medical Center

Related
17 trials

Shared therapeutic areas:

Precursor Cell Lymphoblastic Leukemia-LymphomaRecurrent Adult Acute Myeloid Leukemia
Similarity Score15%

Guillermo Garcia-Manero, MD

M.D. Anderson Cancer Center

Related
18 trials

Shared therapeutic areas:

Myelodysplastic SyndromesPrecursor Cell Lymphoblastic Leukemia-Lymphoma
Similarity Score15%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT01159028Phase 1PrincipalInvestigator

Clinical Trial of BP1001 (L-Grb-2 Antisense Oligonucleotide) in CML, AML, ALL & MDS

Acute Lymphoblastic LeukemiaMyelodysplastic SyndromePh1 Positive CML+1 more
Completed

All 1 trials loaded